Recurrent Anal Canal Carcinoma
2 clinical trials · Condition
◉ Watch Recurrent Anal Canal Carcinoma
| Record | Firm | Date |
|---|---|---|
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers (NCT03439085) | M.D. Anderson Cancer Center | 2018-11-14 |
| Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer (NCT02560298) | ECOG-ACRIN Cancer Research Group | 2016-08-23 |
Track Recurrent Anal Canal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.